Azytro Side Effects

Azithromycin is well tolerated with a low incidence of side effects.
Infections and infestations: Moniliasis and vaginitis.
Blood and Lymphatic System Disorders: Thrombocytopenia. Transient mild reductions in neutrophil counts have occasionally been observed in clinical trials.
Immune system disorders: Anaphylaxis (rarely fatal) (see Precautions).
Metabolism and nutrition disorders: Anorexia.
Psychiatric disorders: Aggressive reaction, nervousness, agitation and anxiety.
Nervous System Disorders: Dizziness, convulsions (as seen with other macrolides), headache, somnolence, parasthesia, hyperactivity and syncope. There have been rare reports of taste perversion.
Ear and Labyrinth Disorders: Vertigo, hearing impairment has been reported with macrolide antibiotics. There have been reports of hearing impairment, including hearing loss, deafness and/or tinnitus in some patients receiving azithromycin. Many of these have been associated with prolonged use of high doses in investigational studies. In those cases where follow-up information were available the majority of these events was reversible.
Cardiac Disorders: Palpitations and arrythmias including ventricular tachycardia (as seen with macrolides) have been reported. There have been rare reports of QT prolongation and torsades de pointes (see Precautions).
Vascular Disorders: Hypotension.
Gastrointestinal Disorders: Nausea, vomiting/diarrhoea (rarely resulting in dehydration), loose stools, dyspepsia, abdominal discomfort (pain/cramps), constipation, flatulence, pseudomembranous colitis, pancreatitis and rare reports of tongue discoloration.
Hepatobiliary Disorders: Abnormal liver function including hepatitis and cholestatic jaundice have been reported, as well as rare cases of hepatic necrosis and hepatic failure, which have rarely resulted in death.
Skin and Subcutaneous Tissue Disorders: Allergic reactions including, pruritus, rash, photosensitivity, oedema, urticaria and angioedema (see Precautions).
Rarely, serious skin reactions including erythema multiforme, Stevens Johnson Syndrome and toxic epidermal necrolysis have occurred.
Musculoskeletal and Connective Tissue Disorders: Arthralgia.
Renal and urinary disorders: Interstitial nephritis and acute renal failure.
General Disorders and Administration Site Conditions: Asthenia, fatigue and malaise have been reported.